Pradžia › Atopinis dermatitas (egzema) › New York
Atopinis dermatitas (egzema) klinikiniai tyrimai New York
16 tyrimai dėl Atopinis dermatitas (egzema) ieško dalyvių vietose New York.
Miestai New York
Oficialus tyrimo tekstas (anglų kalba)
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- OptiSkin Medical, New York
- Equity Medical, LLC, The Bronx
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 72 · Visoms lytims · Atnaujinta 2026-09-29 · NCT06808477Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Brooklyn
Renkami dalyviai2 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, New York
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Montefiore - Jacobi Dermatology Clinic, The Bronx
- Montefiore - Clinical Research Center, The Bronx
- Montefiore - Greene Medical Arts Pavillion, The Bronx
- ir dar 2
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, New York
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07003425Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
Renkami dalyviai
Amžius nuo 13 iki 17 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07746427A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Sadick Research Group, LLC, New York
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-08-28 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 6, Kew Gardens
- Inmagene Site 21, New York
- Inmagene Site 11, Woodbury
Renkami dalyviai2 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-08-12 · NCT07037901Skin Microbial Ecology in Atopic Dermatitis
- University of Rochester Medical Center, Rochester
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 13 ir vyresni · Visoms lytims · Atnaujinta 2026-07-14 · NCT04170244A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
Renkami dalyviai3 fazė
Amžius nuo 18 iki 63 · Visoms lytims · Atnaujinta 2026-07-06 · NCT06389136Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
- University of Rochester Medical Center: Department of Dermatology, Rochester
Renkami dalyviai1 fazė
Amžius 6 ir vyresni · Visoms lytims · Atnaujinta 2026-07-02 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Empire Dermatology, East Syracuse
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- ir dar 1
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-04 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site - Site 7080, Auburn
- Galderma Investigational Site # 7052, East Syracuse
- Galderma Investigational Site - 8282, Mount Kisco
- ir dar 3
Renkami dalyviaiStebimasis tyrimas
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-03-13 · NCT06988605Allergy and Immunology Natural History Study
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Iki 99 metų · Visoms lytims · Atnaujinta 2026-02-04 · NCT05584488Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
- Icahn School of Medicine at Mount Sinai, New York
Renkami dalyviai2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-02-02 · NCT07242638A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- Pfizer, New York
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 0 ir vyresni · Moterims · Atnaujinta 2025-12-09 · NCT05721937Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.